Skip navigation
Por favor, use este identificador para citar o enlazar este ítem: http://rid.unrn.edu.ar/handle/20.500.12049/11016

Título: Resorbed alveolar bone recovery by treatment with pth 1-34 at low doses in experimental periodontitis
Autor(es): Bonanno, Marina Soledad
Zeni Coronel, Estefanía Magalí
Seijo, Mariana
Bidevich, Nicolas Lautaro
Avendaño, Maria Eugenia
Preliasco, Mariana
Davison, Mario Ricardo
Zeni, Susana Noemi
Fecha de publicación: 16-nov-2022
Revista: REUNIÓN CONJUNTA SAIC SAI&FAIC SAFIS 2022
Resumen: We compared two low doses of PTH for the recovery of alveolar bone loss by experimental periodontitis. Periodontitis was induced in 18 female Wistar rats (221±15g); 96 hours later, rats were divided and treated by injection into the gingival sulcus: G1: saline solution (SS), G2 and G3 with 0.2 or 0,4 μg PTH 1-34/Kg/3 times a week. A control group (C) (n=5) without ligature was injected with SS. Af- ter 21 days, serum was extracted to determine CrossLapp (CTX), osteocalcin (OCN) and PTH by ELISA. Animals were euthanized and hemimandibles (HM) and tibias (T) were extracted for histomorphometry (percent bone volume: BV/TB% and periodontal space height: PSA). Results (C, G1, G2 y G3 respectively. Mean±SD, different letters indicate p<0.05): BV/TV% T 45.7±5.4; 41.3±5.4; 46.6±2.7; 44.1±3.0. BV/TV% HM 486±5.6b; 36.4±4.4a; 43.8±1.7ab; 48.7±6.5b. AEP (μm) 168.3±24.2a; 634.2±125.3c; 686.6±71.7c; 354.1±43.6b. CTX (pg/mL) 47.0±15.3a; 71.7±15.7b; 45.4±10.7a; 42.8±9.8a. OCN (ng/mL) 2.4±0.0a; 2.7±0.0c; 2.5±0.1a; 2.6±0.0b. PTH (pg/mL) 17.7±0.5; 16.7±1.2; 13.5±3.9; 13.7±3.5.Tibia BV/TV% did not evidence systemic effects by PTH treatment. Periodontitis increased bone remodeling while PTH treatment decreased bone resorption. G3 showed an increase in OCN levels without changes in CTX levels along with a significant improvement in hemimandible BV/TV% and a high recovery of AEP when compared to C group. Conversely, G1 cannot reach the values of C. Levels of PTH did not change with periodontitis induction or pharmacological treatment. Conclusions: intermittent administration of PTH in the high low dose tested decreased the progression of periodontal disease without inducing systemic effects suggesting an additional successful treat- ment for periodontitis. Grants of CONICET and UNRN
URI: http://rid.unrn.edu.ar/handle/20.500.12049/11016
Otros enlaces: https://drive.google.com/file/d/1XG4tcc9aXzJeCw1uPT5z__Eyly9ShE_q/view
Aparece en las colecciones: Objetos de conferencia

Archivos en este ítem:
Archivo Descripción Tamaño Formato  
Revista Medicina 2022 (1)-281.pdf141,34 kBAdobe PDFVisualizar/Abrir

Este documento es resultado del financiamiento otorgado por el Estado Nacional, por lo tanto queda sujeto al cumplimiento de la Ley N° 26.899


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons